Investing in the Biotech sector arguably carries higher implications for the future of mankind than any other. The capital acquired by pharmaceutical companies is invested into scientific development of drugs designed to combat the world’s most lethal diseases. Such is the importance of developments in medical science, pharmaceutical companies have become incredibly aggressive, with many large firms acquiring smaller ones in order to be the first to clinch scientific breakthroughs. But the biotech industry, like all industries, wants and needs to make money.
The content you are trying to access is only available to users with an FTAdviser.com subscription
Subscribe to FTAdviser now for:
- Full access to articles written by the Money Management team
- No limit to the number of articles you can read every month
- The ability to use Money Management's uniquely prepared fund statistics - on the web, or by downloading a pdf